EV/EBITDA
-0.56
+0.05+8.20%
Wed, 27 Nov 2024 14:30:00 GMT
Summary:
SAB Biotherapeutics EV/EBITDA is currently -0.56, with a rise of +0.05 (+8.20%) during the most recent trading day. Over the past year, it has increased by +1.53 (+73.21%). SABS EV/EBITDA is now -275.00% below its all-time high of 0.32.SABS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +8.2% |
| 1 m1 month | -12.0% |
| 3 m3 months | -51.4% |
| 6 m6 months | -24.4% |
| ytdytd | -64.7% |
| 1 y1 year | +73.2% |
| 5 y5 years | - |
SABS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.50 | -12.0% | -0.92 | +39.1% |
| 3 m | 3 months | -0.33 | -69.7% | -0.92 | +39.1% |
| 6 m | 6 months | -0.24 | -133.3% | -0.92 | +39.1% |
| 1 y | 1 year | 0.32 | -275.0% | -3.45 | +83.8% |
| 3 y | 3 years | 0.32 | -275.0% | -111.60 | +99.5% |
| 5 y | 5 years | 0.32 | -275.0% | -111.60 | +99.5% |
| alltime | all time | 0.32 | -275.0% | -111.60 | +99.5% |
SAB Biotherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.56(+64.7%) |
| 2023 | -0.34(-75.0%) |
| Date | Value |
|---|---|
| 2022 | -1.36(-93.4%) |
| 2021 | -20.72 |
FAQ
- What is SAB Biotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for SAB Biotherapeutics?
- What is SABS EV/EBITDA year-to-date change?
- What is SAB Biotherapeutics EV/EBITDA year-on-year change?
What is SAB Biotherapeutics EV/EBITDA?
The current EV/EBITDA of SABS is -0.56
What is the all time high EV/EBITDA for SAB Biotherapeutics?
SAB Biotherapeutics all-time high EV/EBITDA is 0.32
What is SABS EV/EBITDA year-to-date change?
SAB Biotherapeutics EV/EBITDA has changed by -0.22 (-64.71%) since the beginning of the year
What is SAB Biotherapeutics EV/EBITDA year-on-year change?
Over the past year, SABS EV/EBITDA has changed by +1.53 (+73.21%)